TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Name: TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
License: Public Domain

Roswell Park Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced colorectal carcinoma, metastatic colon adenocarcinoma, metastatic rectal adenocarcinoma, recurrent colon adenocarcinoma, recurrent colorectal adenocarcinoma, recurrent rectal adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 321720
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.